JAK/STAT SIGNALING AS A MEDIATOR OF RESPONSE TO COMBINATION OF FLT3 AND MEK INHIBITORS IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Damnernsawad, Alisa [1 ]
Lerdwattanasombat, Pat [2 ]
Kraikhun, Panssachon [1 ]
Phanochit, Phanuphat [1 ]
Techo, Todsapol [3 ]
Bottomly, Daniel [4 ]
Nechiporuk, Tamilla [5 ]
McWeeney, Shannon [4 ]
Tyner, Jeffrey [5 ]
机构：
[1] Mahidol Univ, Dept Biol, Fac Sci, Bangkok, Thailand
[2] Mahidol Univ, Program Biomed Sci, Fac Sci, Bangkok, Thailand
[3] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Bioinformat & Computat Biol, Portland, OR USA
[5] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR USA
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2023年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [41] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Bartholomew J. Eisfelder
    Caner Saygin
    Joseph Wynne
    Margaret W. Colton
    Mariafausta Fischietti
    Elspeth M. Beauchamp
    Jason X. Cheng
    Olatoyosi Odenike
    Gail Roboz
    Houda Alachkar
    Wendy Stock
    Blood Cancer Journal, 11
  • [42] OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
    Eisfelder, Bartholomew J.
    Saygin, Caner
    Wynne, Joseph
    Colton, Margaret W.
    Fischietti, Mariafausta
    Beauchamp, Elspeth M.
    Cheng, Jason X.
    Odenike, Olatoyosi
    Roboz, Gail
    Alachkar, Houda
    Stock, Wendy
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [43] The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia
    Fathi, Amir T.
    Chen, Yi-Bin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 330 - 336
  • [44] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [45] FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance
    Michael R. Grunwald
    Mark J. Levis
    International Journal of Hematology, 2013, 97 : 683 - 694
  • [46] BETing on rational combination therapy in mutant FLT3 acute myeloid leukemia
    Stone, Richard M.
    HAEMATOLOGICA, 2021, 106 (04) : 931 - 932
  • [47] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    E Chang
    S Ganguly
    T Rajkhowa
    C D Gocke
    M Levis
    H Konig
    Leukemia, 2016, 30 : 1025 - 1032
  • [48] The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond
    Wander, Seth A.
    Levis, Mark J.
    Fathi, Amir T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (03) : 65 - 77
  • [49] FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
    Ahmad I. Antar
    Zaher K. Otrock
    Elias Jabbour
    Mohamad Mohty
    Ali Bazarbachi
    Leukemia, 2020, 34 : 682 - 696
  • [50] In silico and in vitro study of FLT3 inhibitors and their application in acute myeloid leukemia
    Carranza-Aranda, Ahtziri S.
    Jave-Suarez, Luis Felipe
    Flores-Hernandez, Flor Y.
    Huizar-Lopez, Maria Del Rosario
    Herrera-Rodriguez, Sara E.
    Santerre, Anne
    MOLECULAR MEDICINE REPORTS, 2024, 30 (06)
12345